Introduction Peptide Oligonucleotide Conjugate Linker Chemistry plays a key role in how peptide carriers deliver oligonucleotides to intracellular targets. In […]
Linker Chemistry in Peptide-Oligonucleotide Conjugates Read More »
Introduction: A Generic Peptide drug Analytical Characterization case study highlights how advanced analytical science supports regulatory approval of complex generic
Introduction to Types of Peptide Oligonucleotide Conjugates Types of Peptide Oligonucleotide Conjugates are specialized molecular structures where therapeutic oligonucleotides are
Types of Peptide-Oligonucleotide Conjugates Used in Therapeutics Read More »
Introduction The development of synthetic peptide generics derived from recombinant DNA (rDNA) originator products presents important analytical and regulatory challenges.
Introduction: Regulatory Support for generic drugs US and Canada CDMO services play a crucial role in helping pharmaceutical companies successfully
Introduction The Peptide Mapping Study of Semaglutide is an important analytical approach used during the development of synthetic peptide generics
Introduction: When developing a generic drug product, pharmaceutical companies must decide which type of external partner best fits their needs.
CDMO vs CRO for Generic Drug Development: Which Partner Do You Need? Read More »
Introduction Pharmaceutical companies often receive regulatory questions about nitrosamine impurities during submissions, variations, or post-approval reviews. When this happens, organizations
How to Respond to a Regulatory Query on Nitrosamine Risk Assessment Read More »
Introduction Peptide Oligonucleotide Conjugates Preclinical Services play an important role in supporting the development of Peptide Oligonucleotide Conjugates (POCs), which
Introduction: Analytical development for generic drugs Canada is a critical component of successful generic drug development and regulatory approval. Generic
Analytical Development Support from CDMOs for Generic Drug Projects Read More »
